Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 9, 2023
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
Andrew Fein Maintained (CCCC) at Strong Buy with Decreased Target to $17 on, Aug 9th, 2023
Andrew Fein of HC Wainwright & Co., Maintained "C4 Therapeutics, Inc." (CCCC) at Strong Buy with Decreased Target from $25 to $17 on, Aug 9th, 2023.
Andrew has made no other calls on CCCC in the last 4 months.
There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Decreased Target to $10 on, Tuesday, May 30th, 2023
- Terence Flynn of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Friday, May 12th, 2023
